Leaflet LUMERAX 20mg / 120mg tablets

Product code:
W56739001
Quantity:
24
Indicated for:
malaria
Route of administration:
oral
Substance:
artemether + lumefantrine (antimalarials)
ATC
P01BF01 — Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, combinations
Artemether+lumefantrine is a combination medication used in the treatment of uncomplicated malaria caused by Plasmodium falciparum. Artemether is a derivative of artemisinin that acts rapidly against the parasite, while lumefantrine provides a longer-lasting effect, preventing recurrence of the infection.

This combination is administered orally, usually in tablet form, and is recommended as a first-line therapy in many malaria-endemic regions. The treatment is effective in clearing the parasite from the blood and rapidly alleviating symptoms such as fever, chills, and fatigue.

Common side effects include nausea, headache, dizziness, and insomnia. In rare cases, allergic reactions or cardiac disturbances may occur, requiring careful monitoring.

Artemether+lumefantrine is an essential therapeutic option in the fight against malaria, helping to reduce the mortality and morbidity associated with this disease.

General data about LUMERAX 20mg / 120mg

Substance:
artemether + lumefantrine
Date of latest medicines list:
01-07-2013
Product code:
W56739001
Concentration:
20mg / 120mg
Pharmaceutical form:
tablets
Quantity:
24
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.